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Environmental estrogens are endocrine-
disrupting chemicals (EDCs) that can alter 
hormone signaling in the body. Human 
exposure to these chemicals has been 
associated with decreases in semen quality/
sperm count (Li et al. 2011), increased 
incidence of breast cancer (Doherty et al. 
2010) and testicular germ cell cancer (Chia 
et al. 2010), and uro genital tract mal forma tion 
(Fernandez et al. 2012). In a recent study in a 
National Health and Nutrition Examination 
Survey (NHANES) study population, 
Melzer et al. (2010) reported that higher 
urinary levels of the weak environmental 
estrogen bisphenol A (BPA), taken into the 
body via the diet, were associated with heart 
disease and diabetes. In fish, exposure to 
environmental estrogens affects reproductive 
develop ment, causes feminization of males 
(Lange et al. 2009), and alters sexual behaviors 
(Van den Belt et al. 2004; Vos et al. 2000). 
More than 900 chemicals have been identified 
with endocrine-disrupting activity, of which 
200 showed estrogenic effects (Botham 
and Holmes 2005). Major international 
programs have been established to screen 
and test for endocrine-disrupting activity to 
avoid potential human and environ mental 
health risks associated with their exposure 
(e.g., Reif et al. 2010). Critically, however, 
available screening and testing systems for 
estrogens are focused on specific individual 
mechanisms (e.g., estrogen receptor–activated 
cell lines) or in vivo studies that assess effects 
on reproduction only.
The roles of steroid estrogens in repro-
ductive develop ment are well established, 
and many of these roles are common across 
the vertebrate species. Estrogens are funda-
mental in the growth and develop ment of 
the ovary in females (Devlin and Nagahama 
2002; Richards et al. 1976), and they are 
also required for spermato genesis in males 
(Mahato et al. 2001; O’Donnell et al. 2001). 
In addition, estrogens are known to play key 
roles in a wide range of other physiologi-
cal functions, including immune responses, 
the central nervous system, and normal 
somatic cell growth (Filby and Tyler 2005; 
Gustafsson 2003). In mammals, estrogen sig-
naling operates through two different estro-
gen receptors (ERs), ERα and ERβ, which 
have different tissue distributions and regu-
late different estrogen responses (Pettersson 
and Gustafsson 2001). In fish, there are three 
ERs, esr1, esr2a, and esr2b (Filby and Tyler 
2005; Ma et al. 2000; Socorro et al. 2000), 
which also show different patterns of tissue 
expression (Filby and Tyler 2005; Froehlicher 
et al. 2009; Hawkins et al. 2000; Kuiper et al. 
1998; Menuet et al. 2002; Sun et al. 1999; 
Tingaud-Sequeira et al. 2004). However, 
information on the functional distinctions 
between the ERs in fish is lacking.
Understanding the physiological effects of 
estrogenic chemicals would be greatly enhanced 
by in vivo models capable of detecting 
tissue-specific effects of estrogens with 
high sensitivity. Transgenic (TG) zebrafish 
have considerable potential for screening and 
testing EDCs in order to under stand their 
mechanisms of effect and assess their potential 
health impacts in both animals and humans 
(Chico et al. 2008; Moss et al. 2009; Raldua 
and Babin 2009). In the present study, we 
established an estrogen-responsive transgenic 
zebrafish to detect estrogenic signaling of 
natu ral (endogenous) hormones as well as 
exposure to exogenous estrogens, including 
EDCs, in both embryonic and early larval 
stages in real time. The system contains an 
estrogen-inducible promoter that is derived 
from a short stretch of multiple tandem 
estrogen-responsive elements (EREs) and 
is devoid of any tissue-specific enhancer/
suppressor elements. To enhance the system’s 
response sensitivity, we used a Gal4ff-UAS 
(upstream activation sequence) system not 
previously applied in a fish bio sensor system. 
The TG zebrafish produced are highly 
responsive to environ mental estrogens and 
identify a wide range of target tissues, most of 
which have not been reported previously. The 
TG fish further showed that different EDCs 
induced different tissue patterns and response 
time trajectories. Gal4ff-UAS zebrafish 
thus provide a highly effective system for 
studying potential health effects of exposure 
to estrogenic EDCs, as well as a new and 
enhanced capability for screening and testing 
of environmental estrogens.
Address correspondence to C.R. Tyler, Biosciences, 
College of Life and Environmental Sciences, 
University of Exeter, Exeter, Devon, EX4 4PS, UK. 
Telephone: 44 1392 264450. Fax: 44 1392 263434. 
E-mail: c.r.tyler@exeter.ac.uk 
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1104433).
We thank the fish facility for fish husbandry; 
K. Kawakami for the Tol2 system; and S. Wilson, 
A. Kawahara, and M. Itoh for critical comments on 
our data and/or manuscript. 
O.L. was funded by a studentship from Gwanglim, 
Korea, and by the Natural Environmental Research 
Council (reference NE/I014470/1).
The authors declare they have no actual or potential 
competing financial interests.
Received 1 September 2011; accepted 30 March 
2012.
Biosensor Zebrafish Provide New Insights into Potential Health Effects 
of Environmental Estrogens
Okhyun Lee,1 Aya Takesono,1 Masazumi Tada,2 Charles R. Tyler,1 and Tetsuhiro Kudoh1
1Biosciences, College of Life and Environmental Sciences, University of Exeter, Exeter, United Kingdom; 2Department of Cell and 
Developmental Biology, University College London, London, United Kingdom
Background: Environmental estrogens alter hormone signaling in the body that can induce repro-
ductive abnormalities in both humans and wildlife. Available testing systems for estrogens are focused 
on specific systems such as reproduction. Crucially, however, the potential for significant health 
impacts of environmental estrogen exposures on a variety of body systems may have been overlooked.
oBjective: Our aim was to develop and apply a sensitive transgenic zebrafish model to assess real-
time effects of environmental estrogens on signaling mechanisms in a whole body system for use in 
integrated health assessments.
Methods: We created a novel transgenic biosensor zebrafish containing an estrogen-inducible pro-
moter derived with multiple tandem estrogen responsive elements (EREs) and a Gal4ff-UAS system 
for enhanced response sensitivity.
results: Using our novel estrogen-responsive transgenic (TG) zebrafish, we identified target tissues 
for environmental estrogens; these tissues have very high sensitivity even at environmentally rele-
vant concentrations. Exposure of the TG fish to estrogenic endocrine-disrupting chemicals (EDCs) 
induced specific expression of green fluorescent protein (GFP) in a wide variety of tissues including 
the liver, heart, skeletal muscle, otic vesicle, forebrain, lateral line, and ganglions, most of which 
have not been established previously as targets for estrogens in fish. Furthermore, we found that dif-
ferent EDCs induced GFP expression with different tissue response patterns and time trajectories, 
suggesting different potential health effects.
conclusion: We have developed a powerful new model for understanding toxicological effects, 
mechanisms, and health impacts of environmental estrogens in vertebrates.
key words: biosensor, EDCs, endocrine-disrupting chemicals, ER, estrogen receptor, Gal4, 
UAS, upstream activation sequence. Environ Health Perspect 120:990–996 (2012). http://dx.doi.
org/10.1289/ehp.1104433 [Online 18 April 2012]
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Materials and Methods
Fish husbandry and experiments. All experi-
mental procedures conducted with animals 
were in accordance with UK Home Office 
animal procedures [Animal (Scientific 
Procedures) Act 1986] and followed strict 
local ethical review guidelines ensuring their 
humane treatment and with regard to allevia-
tion of suffering. 
Generation of ERE‑green fluorescent pro‑
tein (GFP) transgenic fish. We used poly-





CTGA ATGTGTTAT-5´) for EREs (Sathya 
et al. 1997) were run using polymerase chain 
reaction (PCR) to produce a template (in 
eight cycles: denatura tion at 96°C for 1 min, 
annealing at 60°C for 30 sec, and extension 
at 72°C for 1 min) from which a series of dif-
ferent numbers of tandemly repeated EREs 
were generated. From the ladder of tandem 
EREs generated by PCR, the DNA bands for 
3EREs were cut and inserted into XhoI and 
XbaI fragment sites of pBluescriptKS+ (Agilent 
Technologies, Santa Clara, CA, USA). The 






Gal4ff (amplified by PCR using primers 
5´-GCCGGGCCCGCCACCATGAGCTA
CTGTCTTCT-3´ and 3´-GCGGTACCGA
TTAGTTACCCGGGAGC-5´) and poly A 
sequences, and inserted into pBR322 Tol2 
vector (Kawakami et al. 2004; Urasaki et al. 
2006). The pBR Tol2-3ERE-Gal4ff plasmid 
(18 ng/µL) was injected into one-cell-stage 
embryos for UAS-GFP transgenic zebra fish 
(Kajita et al. 2010) together with transposase 
mRNA (36 ng/µL), and the injected embryos 
were raised to adulthood. Eggs were collected 
from founders and exposed to 100 ng/L 
17α-ethinyl estradiol (EE2) for 3 days, and 
the GFP-positive embryos were selected and 
reared to adulthood. We established three 
stable ERE-TG zebrafish lines from differ-
ent pairs of founder fish (3×ERE:Gal4ff and 
UAS:GFP) that all showed the same GFP 
expression pattern. We used the F2 generation 
of the ERE-TG zebrafish derived from line 
one in all studies reported here.
Zebrafish embryo chemical exposures. 
We selected a series of chemicals to assess the 
responsive ness of our TG zebrafish to estro-
gens, including the natural steroid estro-
gen 17β-estradiol (E2); EE2, which is used 
in contraceptive pills and hormone replace-
ment therapy; BPA, used widely as a plasti-
cizer; and 4-nonyl phenol (NP), used as an 
industrial surfactant (Goodhead and Tyler 
2009). All of these chemicals have been shown 
to contaminate the aquatic environ ment and 
induce feminized responses in fish (Goodhead 
and Tyler 2009; Tyler et al. 1998). E2 (98% 
purity), EE2 (≥ 98% purity), BPA (≥ 99% 
purity), and NP (Acros Organics) were pur-
chased from Sigma Chemical Co. Ltd. (Poole, 
UK). Stock chemicals were dissolved in ace-
tone at 10 mg/L for EE2 and E2, 100 mg/L for 
BPA, and 500 mg/L for NP; solutions were 
prepared in glass bottles and stored at 4°C 
until required. To validate the selectivity of the 
reporter, we also assessed responses to testos-
terone (0.1–10/L) and dexa methasone (Dxm; 
0.1–10 mg/L), which are structurally similar to 
estrogens but are not ER ligands. Testosterone 
and Dxm were dissolved in acetone, as 
described above for estrogens: the stock con-
centrations of 1 mg/L and 1 g/L, respectively. 
The working solutions were prepared 3 days 
before use, with the required amount of stock 
solution pipetted into a glass bottle and the sol-
vent evaporated away under a stream of nitro-
gen. Controls were embryos exposed to culture 
water alone. The working solutions were made 
up in embryo culture water and stirred vigor-
ously for 1 day. Beginning 1 hr post fertilization 
(hpf), TG embryos were exposed to a series 
of chemical concentrations, including those 
with environmental relevance. To confirm that 
estrogenic responses (GFP expression) occurred 
via an ER-mediated pathway, we co-exposed 
TG zebrafish embryos to EE2 and an estro-
gen receptor antagonist [ICI 182,780 (ICI); 
Tocris Bioscience, Bristol, UK]. ICI was dis-
solved in ethanol at a stock concentration of 
50 mg/L, and the working concentration was 
10 µg/L. All experi ments (50 eggs/treatment) 
were run in duplicate and were repeated at 
least five times.
Analysis of EE2 in exposure water. To 
assess the response sensitivity of our ERE-TG 
zebrafish, we measured water EE2 concen-
trations using gas chromatography–mass 
spectrometry (conducted by Severn Trent 
Services, Midlands, UK). Nominal test con-
centrations were highly consistent across the 
range tested, between 68 and 72% of nomi-
nals (specifically, for nominal EE2 exposure 
concentrations of 1, 2.5, and 10 ng/L, mea-
sured levels were 0.72, 1.71, and 7.25 ng/L, 
respectively). Concentrations of EE2 in water 
controls were non detectable (< 0.05 ng/L). 
Quantification of GFP (EGFP) expression 
using Western blot analysis. Four-day-old lar-
vae were dissolved in reduced 2× lithium dode-
cyl sulfate sample buffer (Invitrogen, Carlsbad, 
CA, USA) and homogenized using a hand 
homogenizer. Samples were boiled for 15 min 
at 70°C, centrifuged, and then analyzed by 
electro phoresis using NuPAGE NOVEX 
4–12% Bis-Tris gel (Invitrogen). Separated 
proteins were transferred onto a nitro cellulose 
membrane. The membranes were blocked 
with 5% milk in 1× phosphate-buffered saline 
(PBS) + 0.01% Tween (PBSTx) at room 
temperature for 1 hr and incubated over-
night at 4°C with rabbit anti-GFP antibody 
(1:2,500) (AMS Biotechonology, Abingdon, 
UK). The membrane was then washed three 
times (15 min each) with 1× PBSTx at room 
temperature for 15 min and then incubated 
with horse radish peroxidase–conjugated goat 
anti-rabbit IgG (1:2,000) (Invitrogen) at 
room temperature for 1 hr. The membrane 
was then washed three times with 1× PBSTx 
as described above. For detection, we used 
luminol reagent for Western blotting (Thermo 
Scientific) and analyzed the intensity of GFP 
using ImageJ (http://rsbweb.nih.gov/ij/). 
Results were normalized to the total α-tubulin 
level and are presented as fold increase in GFP 
over the level of unexposed embryos. 
Image analysis. Live larvae were anes-
thetized with 0.4% tricaine, mounted in 
0.7% low-melting agarose in embryo culture 
medium, and placed onto a glass-bottom 
35-mm dish (MatTek, Ashland, MA, USA). 
Images of stained larvae oriented in lateral, 
dorsal, and ventral views were obtained using 
an inverted confocal microscope (Zeiss, 
Cambridge, UK), with a 10× objective lens. 
Z-stacks of line-averaged (four lines) sec-
tions were obtained by scanning the area of 
102.4 µm × 102.4 µm (0.1 µm/pixel) and 
6-µm steps over a total vertical distance of 
180–240 µm, and were reconstituted using 
the LSM510 Meta program (Zeiss). Images 
from parts of the body of larvae were aligned 
and the contrast was adjusted using Adobe 
Photoshop 7 (Adobe Systems, San Jose, 
CA, USA), keeping the same intensity of 
the adjustment for control and all treated 
samples. We used fluorescence microscopy 
(Leica DMI 4000 B; Leica Microsystems 
Ltd., Milton Keynes, Bucks, UK) to examine 
tissue-response dynamics and sensitivity for 
EE2 exposure.
Statistical analysis. All data are reported 
as mean ± SE. Statistical comparisons were 
performed between controls and each exposed 
group using Student’s t-test. Statistical signifi-
cance is indicated at p < 0.05 or p < 0.01. 
Results and Discussion
In creating these fish, we synthesized two 
transgenic vectors that contained ERE-Gal4ff 
and UAS-GFP (Figure 1). The three tandem 
repeats of ERE drive the Gal4ff reporter (a 
modified form of Gal4 transcription factor), 
providing high transcriptional activation with 
low toxicity. The Gal4ff transcription fac-
tor subsequently binds to UAS and activates 
GFP, and the sequential activation of the two 
reporters amplifies the signal. Double TG fish 
(3×ERE:Gal4ff, UAS:GFP) were generated by 
injecting ERE-Gal4ff vector into pre existing 
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UAS-GFP TG fish (Kajita et al. 2010) using a 
Tol2 transposon system (Kawakami et al. 2004; 
Urasaki et al. 2006).
We examined the GFP response to EE2 
in three different ERE-TG zebrafish lines and 
confirmed the same responses across these 
lines. Furthermore, the lines have now been 
maintained over four generations, and the 
pattern of GFP response has not changed, 
indicating that the transgene is very stable 
and that the response is consistent over suc-
cessive generations without a silencing effect. 
Furthermore, we confirmed that the ER 
response to estrogen was specific, because 
neither testosterone (0.1–10 µg/L) nor Dxm 
(0.1–10 mg/L), both of which are structur-
ally similar to estrogens but do not bind to 
ERs, activated the reporter [see Supplemental 
Material, Figure 1 (http://dx.doi.org/10.1289/
ehp.1104433)].
Our examination of GFP expression in 
control 4-day-old TG fish larvae showed 
weak basal GFP expression in the otic vesicle, 
with a 57% frequency, and in the heart, with 
a lower frequency (40%). The variation in 
GFP expression in the unexposed larvae may 
suggest that differences in estrogen levels in 
fish embryos and larvae occur from an early 
develop mental stage. Whether these differences 
relate to sex has not been determined because 
there are no specific sex probes available for 
this species. It is also possible that maternal 
loading of estrogens in the yolk might account 
for the variation in the estrogen signal in the 
TG fish larvae.
Exposure to different estrogens induced 
different tissue patterns of GFP induction 
(Figure 2). In larvae exposed to EE2 
(Figure 2B), GFP expression was observed in 
the liver and forebrain, as has been reported 
with estrogen-responsive TG GFP fish lines 
employing a vitello genin promoter and a 
cyp19a1b promoter, respectively (Bogers et al. 
2006; Chen et al. 2010; Legler et al. 1999; 
Tong et al. 2009). In most estrogen-responsive 
TG fish (both zebrafish and medaka) sys-
tems, responses have largely been restricted to 
the liver and have a relatively low sensitivity 
(Bogers et al. 2006; Chen et al. 2010; Legler 
et al. 1999; Tong et al. 2009). Previously, 
the most sensitive TG fish showed a response 
to EE2 at 10 ng/L after 30 days of exposure, 
as determined by luciferase activity (Bogers 
et al. 2006). In a recently established trans-
genic zebrafish containing GFP and five con-
secutive elements upstream of a c-fos minimal 
promoter, E2 induced GFP expression in the 
heart (Gorelick and Halpern 2011). However, 
these responses were induced by very high 
exposure concentrations of estrogens (E2 at 
1–100 µg/L) that are not environ mentally 
rele vant. In the TG fish in the present study, 
we found specific and strong GFP expression 
in tissues that other bio sensor studies have not 
identified as targets for estrogen, including 
the heart, skeletal muscle, neuro masts, and 
otic vesicle/eye and otic vesicle/eye ganglions 
(Figure 2B,C). In addition, we quantified 
in vivo responses to environ mentally rele vant 
doses of estrogens in real time. GFP expression 
in the heart was confirmed by the periodi cal 
contractile movement of the two GFP express-
ing domains in the artery and in the ventricle, 
synchronizing with the heart beat in the live 
fish. GFP expression in somite muscle was 
more intense in anterior somites than in poste-
rior somites at early larval stages, but posterior 
expression increased gradually over time in 
later larval stages. Each expression domain 
outlined the shape of a single muscle myo-
tube. Interestingly, with low EE2 exposures 
GFP expression in muscle somites was often 
observed as a mosaic pattern (it was expressed 
in only some of the myotubes). At high EE2 
exposure, GFP expression was present in a 
uniform manner in the myotubes. 
We also observed specific GFP expres-
sion in the neuromasts of the lateral line of 
the head and in ganglions adjacent to the 
otic vesicles and eyes, which showed typi-
cal large masses of neurons and neurite (see 
Figure 2Ci,Dii for responses to E2 and BPA, 
respectively). Although neuro mast-specific 
responses to estrogens have not been reported 
in other biosensor fish, esr2a and esr2b are 
highly expressed in the neuromasts, and 
knockdown of esr2b abolishes neuro mast 
develop ment, indicating a crucial role of 
ER signaling for neuro mast development/
function (Froehlicher et al. 2009; Tingaud-
Sequeira et al. 2004). The GFP tissue expres-
sion pattern induced by natural steroidal 
estrogen (E2) is similar to that induced by EE2 
(Figure 2B,C). Studies using real-time PCR 
have shown that ER transcripts are expressed 
in the liver, heart, brain, testis, and kidney 
after exposure to estrogen (Chandrasekar 
et al. 2010), which is consistent with the GFP 
responses in our TG fish.
In embryos exposed to BPA, we observed 
strong GFP expression in the heart, cranial 
muscle, and otic vesicle and retinal ganglions 
with long neurites (Figure 2Di,Dii). In con-
trast to EE2 and E2 exposures, GFP expres-
sion in liver and somite muscle were relatively 
weak in response to BPA. GFP expression 
induced by NP was strongest in the liver and 
somite muscle but was less intense in the otic 
vesicle and heart (Figure 2E). These expres-
sion patterns suggest that different estrogens 
have common target tissues (e.g., liver, heart, 
muscle, otic vesicle), but they have different 
degrees of effect on the different tissues (i.e., 
tissue-specific responsiveness), with different 
potential health effect outcomes.
To understand stage-dependent tissue 
responses to estrogen, we examined the 
response dynamics of different tissues after 
exposure to EE2 (100 ng/L) from 1 hpf 
to 96 hpf (Figure 3I). We observed GFP 
expression at 24 hpf in the liver, heart, and 
muscle; expression increased progressively 
until 96 hpf, when it reached a maximal 
expression level. In contrast, GFP expression 
in the brain and nervous system appeared 
later in development; GFP was seen in the 
otic vesicle only after 48 hpf, and in the eye 
and forebrain after 72 hpf (Figure 3I). Data 
Figure 1. 3ERE‑Gal4ff/UAS‑GFP system in zebrafish. (A) The ERE‑Gal4ff transgene contains three synthetic 
EREs, one TATA, a Gal4ff reporter, and two Tol2 elements; and the UAS‑GFP transgene contains five 
tandem repeats of the UAS‑Gal4 binding sequence, an E1B minimal promoter, and an EGFP reporter. An 
estrogenic signal is detected when the chemical–ER complex binds to the ERE, which activates Gal4ff; 
subsequently, Gal4ff protein binds to UAS to induce EGFP. (B,C) Induction of GFP in larvae of ERE‑Gal4ff/
UAS‑GFP double transgenic fish. Four‑day‑old larvae were exposed to water alone (control; B) or E2 
(100 ng/L). GFP expression (green) is present in the cranial muscle (cm), heart (h), lens (le), liver (li), neuro‑
mast (n), and somite muscle (sm). Bar = 200 µm. 
Tol2 ERE TATA Gal4ff PolyA Tol2
Tol2 UAS E1B GFP PolyA Tol2
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indicate that estrogenic exposure affects 
different tissues in a life-stage–dependent 
manner, and illustrate the usefulness of the 
ERE-TG fish model in investigating time-
related effects of estrogens in an intact animal. 
ERE-TG fish embryos were exposed to 
various concentrations of the selected EDCs 
(Figure 3) to determine whether they were 
capable of detecting responses for exposures 
to environmentally relevant concentrations. 
Responses to the most potent estrogen, EE2, 
were titrated down to 1 ng/L (measured 
concentration, 0.72 ng/L), where a low-level 
GFP response was induced in cells in the liver 
(Figure 3Bi). Higher exposure concentrations 
resulted in progressively higher GFP expression 
levels, and a nominal concentration of 
EE2 (10 ng/L; measured concentration, 
7.25 ng/L) induced considerable expression 
throughout the liver; this was accompanied 
by GFP expression in the muscle (somite 
and cranial muscle) and heart (Figure 3D). 
Concentration-dependent GFP expression was 
further confirmed quantitatively via Western 
blot analyses. The level of GFP expression 
increased dramatically and in a concentration-
dependent manner for both EE2 (1–10 ng/L; 
Figure 3B–D,J,K) and E2 (5–10 ng/L) 
(Figure 3E,F,L). The threshold concentrations 
for NP and BPA (1 µg/L and 100 µg/L, 
respectively) were significantly higher, showing 
a low relative potency of these environmental 
estrogens compared to the steroidal estrogens 
EE2 and E2 (Figure 3G,H,M,N). Both BPA 
and NP also bind to other soluble receptors, 
such as the androgen receptor and the thyroid 
hormone receptor; these activities could 
influence pathways that intersect with the ER 
pathway.
To examine whether estrogen-induced 
GFP expression in ERE-TG fish was medi-
ated via ERs, we conducted additional experi-
ments to specifically suppress ER activity 
in the ERE-TG zebrafish by adding ICI to 
the embryo culture. Exposure of ERE-TG 
zebrafish larvae to ICI (Figure 4Bi) abolished 
GFP expression observed in the otic vesicles 
of non exposed fish (Figure 4Ai). Moreover, 
exposure to EE2 plus ICI (Figure 4Di,Dii) 
greatly reduced GFP expression in all of 
the tissues (i.e., liver, heart, muscle, neuro-
masts, ganglions) compared with EE2 alone 
(Figure 4Ci,Cii). Consistent with the fluo-
rescent imaging data, Western blot analysis 
confirmed that ICI treatment led to drastic 
inhibition of both basal GFP expression in 
control fish and GFP expression in EE2-
treated fish (Figure 4E). These data suggest 
that a major part of GFP response in these TG 
fish is mediated by the ERs.
The functional consequences of environ-
mental estrogen exposures—especially during 
early life—are uncertain, and information 
concerning the molecular mechanisms 
underlying estrogen-mediated physiologi-
cal and pathological consequences of these 
exposures is limited. Transgenic zebrafish 
and medaka (Oryzias latipes) have been 
developed previously to detect exposure to 
environ mental estrogens, but expression 
of the reporter genes in these fish has been 
restricted to the liver and gonads, most likely 
because the gene-specific promoters used 
(e.g., vitello genin) are predominantly active in 
Figure 2. Expression of GFP in transgenic zebrafish larvae exposed to estrogenic chemicals shown in 
the head with lateral (i) and ventral (ii) views and in the trunk with lateral view (iii). Transgenic zebrafish 
larvae were exposed to water alone (control; A), EE2 (100 ng/L; B), E2 (100 ng/L; C), BPA (1 mg/L; D), or NP 
(10 µg/L; E) for 4 days. GFP induction was observed in the otic vesicle (ov) in the control larvae (A), but the 
estrogenic chemicals induced different tissue patterns of GFP expression (B–E). EE2 (B) and E2 (C) induced 
GFP expression in cranial muscles (cm), fin (f), forebrain (fb), heart (h), lens (le), liver (li), neuromast (n), 
ov, ov ganglions (ovg), pectoral fin (pf), retinal ganglions (rg), and somite muscles (sm). In BPA‑exposed 
larvae (D), h and cm expression was enhanced; in NP‑exposed larvae (E), strong GFP expression was 
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Figure 3. GFP expression in transgenic zebrafish embryos. GFP expression in control (unexposed) embryos (A) or in embryos exposed to EE2 (1, 2.5, and 10 ng/L; 
B–D), E2 (5 and 10 ng/L; E,F), BPA (100 µg/L; G) or NP (1 µg/L; H). Bars = 100 µm. Images focus on liver (lateral view; i), heart (ventral view; ii), and somite muscle 
(lateral view; iii). GFP expression was detected in the liver after exposure to EE2 at 1 ng/L (Bi) and in liver, heart, and somite muscle after exposure to EE2 at 2.5 and 
10 ng/L (C,D). After E2 exposure, a few GFP‑expressing cells were observed in the liver at 5 ng/L (Ei), whereas strong GFP expression was detected in the liver and 
heart after exposure to E2 at 10 ng/L (F). After BPA exposure, GFP was preferentially expressed in the heart (Gii), but not in the liver or somite muscle (Gi,Giii). Weak 
GFP expression was detected in the heart and somite muscle after NP exposure (Hii,Hiii). Red boxes indicate GFP expression in the heart. Time‑related (I ) and 
concentration‑dependent (J) analyses of GFP expression performed 4 days after EE2 exposure. (K–N) Dose response of GFP induction by EE2 (K), E2 (L), BPA (M), 
and NP (N) measured by Western blotting. α‑Tubulin was used as a loading control; analyses were conducted three times, and data are reported as mean ± SE. 
*p < 0.05, and **p < 0.01 compared with control. 
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these tissues (Legler et al. 1999; Salam et al. 
2008; Zeng et al. 2005). The system described 
here employs a synthetic ERE that lacks any 
additional enhancer/suppressor elements that 
could bias the estrogen response or restrict it 
to specific tissues. Therefore, our model can 
detect estrogenic responses in a wider range of 
tissues than other available TG fish systems.
Our modified reporter system consider-
ably enhances sensitivity in a variety of tissues, 
allowing us to detect responses to chemical 
exposures at environmentally relevant concen-
trations. Although we identified several novel 
target tissues for estrogens, we used only one 
type of ERE and surrounding sequence, which 
will not be effective for all estrogenic signaling 
systems. Specifically, ERs that work through 
Sp1 or AP1 sites would not be detected by 
this assay, nor would EREs with half-binding 
sites only.
Specific cell types in liver, gonad, and 
forebrain are responsive to estrogen (Chen 
et al. 2010; Hano et al. 2007; Legler et al. 
1999; Tong et al. 2009), and neuro mast cells 
have elevated expression levels of esr2 genes 
(Froehlicher et al. 2009). In addition to these 
target tissues, we demonstrate for the first 
time that muscle (somite and cranial), heart, 
and many ganglion cells also respond to estro-
gen exposure, thus activating the estrogen 
signaling cascade in these cells. E2 caused a 
significant increase in expression of esr1 and 
esr2 in cardiac myocytes, in which estrogen 
regulates expression of specific cardiac genes 
(Kahlert et al. 1997). Furthermore, exposure 
to the environmental estrogen BPA has been 
reported to result in heart defects (Melzer 
et al. 2010). These data, together with our 
finding of specific responses of GFP to estro-
gens, suggest a crucial role of estrogenic sig-
naling in the developing heart. Identifying 
target genes of the estrogenic signaling cascade 
in these tissues, as well as detailed analyses 
of the processes affected, will help in under-
standing the functional significance of these 
responses. Despite the fact that three ERs are 
known to be expressed widely in the embryo 
and larvae of fish (Froehlicher et al. 2009; 
Tingaud-Sequeira et al. 2004), we detected 
estrogenic GFP responses in our TG fish only 
in a limited number of tissues (e.g., heart, 
muscle, brain); this may indicate that estrogen 
signaling requires tissue-specific cofactors or 
coreceptors to activate the estrogen cascade 
and/or that signaling operates through the 
membrane-associated ER GPR30 (G protein-
coupled receptor 30) in some tissues (Filardo 
et al. 2007; Revankar et al. 2005). Tissue-
specific estrogenic responses differed among 
the environ mental estrogenic chemicals we 
tested. For instance, BPA caused a strong 
response in the heart, whereas NP caused 
a more potent response in skeletal muscle. 
These findings suggest that although these 
chemicals are both classified as environmental 
estrogens, they may have different effects on 
health. Future investigations of tissue-specific 
responses should help determine whether this 
is indeed the case.
Our TG system effectively detected 
responses to environmental estrogens (NP 
and BPA) of a comparatively weak potency 
compared with steroidal estrogens, and tissue 
response patterns differed for the different 
estrogens tested. This suggests that the sys-
tem has considerable potential for screening 
and characterizing estrogenic properties of 
chemicals and that it offers a new model for 
under standing effect mechanisms. Applied to 
embryos/larval stages, this system could be 
developed as a high through put screening sys-
tem, similar to zebrafish embryo systems used 
to test drugs in the pharmaceutical industry 
(Chakraborty et al. 2009; Xu et al. 2010).
We have developed a powerful model 
system that can be used to screen and test 
environ mental estrogens, allowing for tar-
geting of tissue-specific studies to identify 
molecular mechanisms that under lie estrogen 
signaling pathways, and for under standing 
the physio logi cal and pathological impacts of 
these compounds. 
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